SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-24-009903
Filing Date
2024-08-02
Accepted
2024-08-02 17:16:49
Documents
18
Period of Report
2024-08-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 30551
2 OPINION drma_ex51.htm EX-5.1 7873
8 drma_ex51img3.jpg GRAPHIC 5039
9 drma_ex51img5.jpg GRAPHIC 6569
  Complete submission text file 0001654954-24-009903.txt   201567

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drma-20240802.xsd EX-101.SCH 6154
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20240802_lab.xml EX-101.LAB 16881
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20240802_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20240802_pre.xml EX-101.PRE 12339
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20240802_def.xml EX-101.DEF 4200
20 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 5818
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 241172204
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)